Preparing for pharmacist independent prescribing at scale

From 2026 new pharmacy registrants in the UK register as Independent Prescribers (IPs). There is a 2024 government manifesto commitment to introduce a community pharmacy prescribing service in England. This perspective piece follows up on findings from previous research(1). It has been written as information for policy makers, commissioners and educators to support the successful rollout of pharmacist independent prescribing, particularly within the community pharmacy sector. Twenty-two semi-structured interviews identified work already underway, and the three priority areas for further action:1. Newly qualified prescribers need to start using the competencies that underpin prescribing, which may include writing prescriptions, with support, immediately after qualifying; 2. Ongoing support is critical and a shared responsibility between prescribers, employers and commissioners, should be built into commissioning frameworks;3. Increased experiential learning should be built into all undergraduate and post-graduate training programmes.Key challenges identified included: delayed prescribing start, support gaps, placement challenges, governance variability, risk culture, liability confusion and performance oversight.Conclusion: Community pharmacy can become a frontline prescribing service in England if education, support, governance and culture are aligned and resourced. Immediate next steps could include planned transition from Patient Group Directions (PGDs) to commissioned IP services, prioritised commissioning of support hubs and funding of simulation/placement capacity.